NUTAMED

NUTAMED has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €288,418 and a net result of €27,708. Equity is growing by ~17.6% per year across the filed fiscal years. Its solvency ranks better than 82% of 979 sector peers (NACE 10, fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).